| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Cytokinetics, Incorporated (CYTK) have been net sellers, shedding 183,926 shares worth roughly $12.9M on balance. In the past 30 days, 0 insiders bought and 2 sold.
All 2 insiders who sold still hold shares after their sales. Classified under Biotechnology (Health Care sector), CYTK's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 278.5K | $2.95M | -15,000 | |
| VP | 153.9K | $9.85M | -7,000 | |
| Other | 107.9K | - | - | |
| Dir | 78.7K | $5.03M | - | |
| CFO | 63.2K | $3.07M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | Malik Fady Ibraham54 | EVP Research &Development | Sale+OE | 3,500 | $64.01 | $224,035.00 | -2.2% | - | - | |
| Oct 12, 2026 | Blum Robert I50 | President &CEO | Sale+OE | 7,500 | $62.88 | $471,600.00 | -2.6% | - | - | |
| Oct 6, 2026 | Malik Fady Ibraham54 | EVP Research &Development | Sale+OE | 3,500 | $61.38 | $214,830.00 | -2.2% | - | - | |
| Sep 28, 2026 | Blum Robert I50 | President &CEO | Sale+OE | 7,500 | $65.46 | $490,950.00 | -2.6% | - | - | |
| Sep 22, 2026 | Malik Fady Ibraham54 | EVP Research &Development | Sale+OE | 3,500 | $68.29 | $239,015.00 | -2.2% | - | - | |
| Sep 15, 2026 | Landry Robert E52 | Director | Sell | 1,000 | $72.13 | $72,130.00 | -10.9% | - | - | |
| Sep 15, 2026 | Blum Robert I50 | President &CEO | Sale+OE | 105,426 | $69.62 | $7,340,009.58 | - | - | - | |
| Sep 11, 2026 | Landry Robert E52 | Director | Sell | 1,000 | $74.66 | $74,660.00 | -9.8% | - | - | |
| Sep 8, 2026 | Malik Fady Ibraham54 | EVP Research &Development | Sale+OE | 3,500 | $75.46 | $264,110.00 | -2.2% | - | - | |
| Sep 1, 2026 | Parshall B Lynne74 | Director | Sell | 5,000 | $71.48 | $357,400.00 | -31.7% | - | - |